Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area

Showing 1161 - 1170 of 1173 for "United States" with applied filters

News & Analysis

LMG Life Sciences Americas Awards: 2022 winners now live

09 September 2022 by LMG Life Sciences

Results from the awards research period were announce in New York on Sept. 8

News & Analysis

LMG Life Sciences Americas Awards: 2022 shortlists announced

21 July 2022 by LMG Life Sciences

In-person ceremony will be held on September 8 at Essex House in New York

News & Analysis

LMG Life Sciences Americas 2022 submission period officially extended

26 May 2022 by Chris Adams

Research team will now accept submissions up to June 15

News & Analysis

LMG Life Sciences Americas 2022: research has now begun

23 March 2022 by LMG Life Sciences

Research team is now accepting submissions, with a deadline set for June 1

News & Analysis

2022 Americas research period will launch on March 24

21 March 2022 by LMG Life Sciences

Research forms will be available on Thursday, with submissions due on June 1

News & Analysis

LMG Life Sciences Americas Awards: 2021 winners revealed

23 September 2021 by Chris Adams

Honorees were announced during a Sept. 22 awards dinner in New York

News & Analysis

2021 North America research deadline extended

27 May 2021 by LMG Life Sciences

Firms can now provide submissions up to June 10

News & Analysis

Licensing tips from a patent litigator

06 September 2017 by LMG Life Sciences

Anyone drafting patent license agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly.

News & Analysis

Beyond Biosimilarity: Draft Guidance for Demonstrating Biological Interchangeability

06 September 2017 by LMG Life Sciences

The primary focus of the Food and Drug Administrationtion, industry and counsel preparing for the advent of follow-on biologics in the United States has been the legal and regulatory framework ...

News & Analysis

To Modify or Not to Modify, That is the Question

06 September 2017 by LMG Life Sciences

In IPRs regarding the patents to pharmaceutical compounds, patentability often turns on the obviousness of taking a known compound and modifying it based on a known technique.